Guy Cameron


Immunologist & Med student

IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis


Journal article


M. R. Starkey, M. W. Plank, P. Casolari, A. Papi, S. Pavlidis, Y. Guo, G. J. M. Cameron, T. J. Haw, A. Tam, M. Obiedat, C. Donovan, N. G. Hansbro, D. H. Nguyen, P. M. Nair, R. Y. Kim, J. C. Horvat, G. E. Kaiko, S. K. Durum, P. A. Wark, D. D. Sin, G. Caramori, I. M. Adcock, P. S. Foster, P. M. Hansbro
Eur Respir J, 2019


Cite
close

Cite

APA
Starkey, M. R., Plank, M. W., Casolari, P., Papi, A., Pavlidis, S., Guo, Y., … Hansbro, P. M. (2019). IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J, 54.

Chicago/Turabian
Starkey, M. R., M. W. Plank, P. Casolari, A. Papi, S. Pavlidis, Y. Guo, G. J. M. Cameron, et al. “IL-22 and Its Receptors Are Increased in Human and Experimental COPD and Contribute to Pathogenesis.” Eur Respir J 54 (2019).

MLA
Starkey, M. R., et al. “IL-22 and Its Receptors Are Increased in Human and Experimental COPD and Contribute to Pathogenesis.” Eur Respir J, vol. 54, 2019.